Showing all 16 results
Alfuzosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer or Capsule-in-Tablet format, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Dutasteride.
Active Ingredient Strength Primary Clinical Function Alfuzosin HCl (Extended-Release) USP/BP 10 mg The Rapid Reliever: Provides immediate improvement in urine flow by relaxing prostate muscles. Dutasteride USP/BP 0.5 mg The Long-Term Shaper: Reduces the physical size of the prostate to prevent the need for surgery. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide synchronized 24-hour therapeutic coverage with once-daily dosing. Alfuzosin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release (ER) Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Alfuzosin Hydrochloride USP/BP 10 mg The Standard Therapeutic Anchor: The globally validated once-daily dose for moderate-to-severe BPH symptoms. Excipients Extended-Release Matrix Controlled-Delivery System: Engineered to provide synchronized 24-hour therapeutic coverage, eliminating the need for multiple daily doses. Bethanecol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in secure Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bethanechol Chloride USP/BP 10 mg The Pediatric & Titration Unit: Ideal for initial dosing or mild cases of gastric atony. Bethanechol Chloride USP/BP 25 mg The Urology Anchor: The standardized therapeutic dose for managing post-operative urinary retention. Excipients Proprietary Matrix Acid-Stable Formulation: Engineered to survive the gastric environment for consistent intestinal absorption. Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly potent active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Finasteride USP/Ph.Eur. 1 mg The Global Dermatology Standard: The definitive micro-dose engineered specifically for the lifelong, daily maintenance of Androgenetic Alopecia (Male Pattern Hair Loss). Finasteride USP/Ph.Eur. 5 mg The Global Urology Standard: High-efficacy macro-dose utilized for the aggressive shrinkage of the prostate gland in symptomatic Benign Prostatic Hyperplasia (BPH). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Docusate Sodium / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Opadry Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the teratogenic API, ensuring absolute safety for female pharmacists and caregivers handling the medication) *Pack Sizes: 10×10 Blisters or Bottles of 30/100 (Optimized specifically for strict, lifelong chronic urology and dermatology dispensing regimens).
Flavoxate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flavoxate Hydrochloride USP/Ph.Eur. 200 mg The Global Urological Standard: The definitive macrodose therapeutic unit utilized for rapid, acute suppression of agonizing bladder spasms and chronic overactive bladder maintenance. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing advanced “Rapid-Burst” superdisintegrants to ensure the massive 200mg tablet shatters instantly upon contact with gastric fluid, guaranteeing hyper-fast pain relief while masking the bitter taste) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 3-to-4 times daily acute dispensing regimens).
Flutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the antiandrogen API.
Active Ingredient Strength Primary Clinical Function Flutamide USP/Ph.Eur. 250 mg Global Uro-Oncology Standard: The definitive therapeutic unit utilized for chronic, 8-hourly maintenance in Maximum Androgen Blockade (MAB) protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the potent antiandrogen API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous hormonal dust) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic oncology dispensing regimens).
Mirabegron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.
Active Ingredient Strength Primary Clinical Function Mirabegron Ph.Eur./USP 25 mg (ER) Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment. Mirabegron Ph.Eur./USP 50 mg (ER) Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity. Excipients Polyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry Film Swellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).
Nitrofurantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.
Active Ingredient Strength Primary Clinical Function Nitrofurantoin (Macrocrystals) USP/Ph.Eur. 50 mg Prophylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing. Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP 100 mg Global Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis. Excipients Carbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant PVC/PVDC or Alu-PVC blister strips to ensure the stability of the active dye compound.
Active Ingredient Strength Primary Clinical Function Phenazopyridine Hydrochloride USP/Ph.Eur. 100 mg Standard OTC/Initiation dose for mild-to-moderate urinary tract discomfort. Phenazopyridine Hydrochloride USP/Ph.Eur. 200 mg Global Prescription Standard: Maximum adult dose for severe dysuria and post-operative catheter trauma. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for rapid gastric dissolution and swift renal clearance) Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.
Active Ingredient Strength Primary Clinical Function Phenazopyridine HCl USP/Ph.Eur. 100 mg OTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief. Phenazopyridine HCl USP/Ph.Eur. 200 mg Prescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax Coating Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).
Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.
Active Ingredient Strength Primary Clinical Function Solifenacin Succinate USP/Ph.Eur. 5 mg Global Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment. Solifenacin Succinate USP/Ph.Eur. 10 mg High-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency. Excipients Lactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / Macrogol Diluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection) Tamsulosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Dutasteride USP/Ph.Eur. 0.5 mg Dual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction. Excipients Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation) Tamsulosin & Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Finasteride USP/Ph.Eur. 5 mg Targeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate SR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation) Tamsulosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.
Active Ingredient Strength Primary Clinical Use Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release Tablet) Premium Global Standard: Target once-daily, food-independent adult dose for BPH. Excipients Macrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron Oxide Advanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)
